To measure the effect of DKK1 on the inflammation that accompanies tumor progression, qPCR and ELISA were performed to determine the expression levels of the proinflammatory cytokines TNF-α, IL-6, and IL-1ẞ after DKK1 treatment. Here, DKK1 is linked to neoplasm.